Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02064543 · ClinicalTrials.gov registry record
Measurement of Gait Using Opal APDM and Gait Mat in Parkinsonism
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 24
- Enrollment target
NCT02064543 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 24 participants.
The verdict
NCT02064543 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The project is a prospective trial comparing Zeno/GAITRite and APDM® in a cohort of persons living with parkinsonian disorders. Ambulatory patients with a parkinsonian syndrome and who are able to provide informed consent will participate in the assessments. Outcome variables include selected gait and balance parameters such as cadence, gait-cycle, stride-length, stride-velocity, turning duration, turning steps, postural sway and anticipatory postural control. These parameters will be measured by the portable inertial sensors developed by APDM® and the Zeno/GaitRite.
Interventions
- OTHER GAITRite
- OTHER ADPM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-07 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02064543
The ClinicalTrials.gov registry entry for NCT02064543 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which GAITRite is the first listed.
NCT02064543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02064543 about?
NCT02064543 is a clinical study titled "Measurement of Gait Using Opal APDM and Gait Mat in Parkinsonism". The project is a prospective trial comparing Zeno/GAITRite and APDM® in a cohort of persons living with parkinsonian disorders. Ambulatory patients with a parkinsonian syndrome and who are able to provide informed consent will participate in the assessments. Outcome variables include selected gait ...
What is the current status of trial NCT02064543?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2013-07. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02064543?
The interventions under investigation include: GAITRite (OTHER), ADPM (OTHER).
Who is sponsoring clinical trial NCT02064543?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.